Zobrazeno 1 - 10
of 185
pro vyhledávání: '"Caniego-Casas T"'
Autor:
Moreno-Moreno E; Department of Pathology.; Department of Medical Oncology., Caniego-Casas T; Department of Pathology.; Clinical Biostatistics Unit., Carretero-Barrio I; Department of Pathology.; Department of Medical Oncology.; Clinical Biostatistics Unit., Cortés A; Clinical Biostatistics Unit.; Radiation Oncology Department., Muriel A; Department of Obstetrics and Gynecology, Ramón y Cajal University Hospital, Ramón y Cajal Health Research Institute (IRYCIS).; Centre for Biomedical Research in Cancer Networks (CIBERONC), Carlos III Health Institute.; Centre for Biomedical Research in Epidemiology and Public Health Networks (CIBERESP), Carlos III Health Institute., Domínguez-Rullán JA; Department of Biochemistry, Autonomous University of Madrid (UAM), 'Alberto Sols' Biomedical Research Institute, Cancer Connection (UAM-CSIC)., Martín-Gromaz C; MD Anderson International Foundation., Moreno-Bueno G; Clinical Biostatistics Unit.; Faculty of Medicine.; Nursery Department and Physiotherapy, Alcalá University., Matías-Guiu X; Clinical Biostatistics Unit.; Department of Pathology and Medical Oncology, Arnau de Vilanova University Hospital, IRBLLEIDA, University of Lleida.; Department of Pathology, Bellvitge University Hospital, IDIBELL, University of Barcelona., Palacios J; Department of Pathology.; Department of Medical Oncology.; Clinical Biostatistics Unit., Pérez-Mies B; Department of Pathology.; Department of Medical Oncology.; Clinical Biostatistics Unit.
Publikováno v:
The American journal of surgical pathology [Am J Surg Pathol] 2024 Sep 13. Date of Electronic Publication: 2024 Sep 13.
Autor:
Ruz-Caracuel I; Pathology Department, Hospital Universitario Ramón y Cajal, IRYCIS, 28034, Madrid, Spain. Ignacio.ruz@salud.madrid.org.; CIBER-Cáncer (CIBERONC), Madrid, Spain. Ignacio.ruz@salud.madrid.org., Caniego-Casas T; Pathology Department, Hospital Universitario Ramón y Cajal, IRYCIS, 28034, Madrid, Spain.; CIBER-Cáncer (CIBERONC), Madrid, Spain., Alonso-Gordoa T; Medical Oncology Department, Hospital Universitario Ramón y Cajal, IRYCIS, 28034, Madrid, Spain., Carretero-Barrio I; Pathology Department, Hospital Universitario Ramón y Cajal, IRYCIS, 28034, Madrid, Spain.; CIBER-Cáncer (CIBERONC), Madrid, Spain.; Medicine School, Alcalá University, 28805, Madrid, Spain., Ariño-Palao C; Pathology Department, Hospital Universitario Ramón y Cajal, IRYCIS, 28034, Madrid, Spain.; Medicine School, Alcalá University, 28805, Madrid, Spain., Santón A; Pathology Department, Hospital Universitario Ramón y Cajal, IRYCIS, 28034, Madrid, Spain.; CIBER-Cáncer (CIBERONC), Madrid, Spain., Rosas M; Pathology Department, Hospital Universitario Ramón y Cajal, IRYCIS, 28034, Madrid, Spain., Pian H; Pathology Department, Hospital Universitario Ramón y Cajal, IRYCIS, 28034, Madrid, Spain., Molina-Cerrillo J; Medical Oncology Department, Hospital Universitario Ramón y Cajal, IRYCIS, 28034, Madrid, Spain., Luengo P; General Surgery Department, Hospital Universitario Ramón y Cajal, IRYCIS, 28034, Madrid, Spain., Palacios J; Pathology Department, Hospital Universitario Ramón y Cajal, IRYCIS, 28034, Madrid, Spain.; CIBER-Cáncer (CIBERONC), Madrid, Spain.; Medicine School, Alcalá University, 28805, Madrid, Spain.
Publikováno v:
Endocrine pathology [Endocr Pathol] 2024 Sep; Vol. 35 (3), pp. 207-218. Date of Electronic Publication: 2024 Jul 03.
Autor:
González-Martínez S; 'Contigo Contra el Cáncer de la Mujer' Foundation, 28010, Madrid, Spain.; Molecular Pathology of Cancer Group, Ramón y Cajal Health Research Institute (IRYCIS), 28034, Madrid, Spain.; Centre for Biomedical Research in Cancer Networks (CIBERONC), Carlos III Health Institute, 28029, Madrid, Spain., Kajabova VH; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska Cesta 9, 84505, Bratislava, Slovakia., Pérez-Mies B; Molecular Pathology of Cancer Group, Ramón y Cajal Health Research Institute (IRYCIS), 28034, Madrid, Spain.; Centre for Biomedical Research in Cancer Networks (CIBERONC), Carlos III Health Institute, 28029, Madrid, Spain.; Department of Pathology, Ramón y Cajal University Hospital, 28034, Madrid, Spain.; Faculty of Medicine, University of Alcalá, 28801, Madrid, Spain., Carretero-Barrio I; Molecular Pathology of Cancer Group, Ramón y Cajal Health Research Institute (IRYCIS), 28034, Madrid, Spain.; Centre for Biomedical Research in Cancer Networks (CIBERONC), Carlos III Health Institute, 28029, Madrid, Spain.; Department of Pathology, Ramón y Cajal University Hospital, 28034, Madrid, Spain.; Faculty of Medicine, University of Alcalá, 28801, Madrid, Spain., Caniego-Casas T; Molecular Pathology of Cancer Group, Ramón y Cajal Health Research Institute (IRYCIS), 28034, Madrid, Spain.; Centre for Biomedical Research in Cancer Networks (CIBERONC), Carlos III Health Institute, 28029, Madrid, Spain., Sarrió D; Centre for Biomedical Research in Cancer Networks (CIBERONC), Carlos III Health Institute, 28029, Madrid, Spain.; Department of Biochemistry, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols', Conexión Cáncer (UAM-CSIC), 28029, Madrid, Spain., Moreno-Bueno G; Centre for Biomedical Research in Cancer Networks (CIBERONC), Carlos III Health Institute, 28029, Madrid, Spain.; Department of Biochemistry, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols', Conexión Cáncer (UAM-CSIC), 28029, Madrid, Spain.; MD Anderson Internacional Foundation, 28033, Madrid, Spain., Gión M; Department of Medical Oncology, Ramón y Cajal University Hospital, 28034, Madrid, Spain., Perez-García J; 'Contigo Contra el Cáncer de la Mujer' Foundation, 28010, Madrid, Spain.; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron-salud Group, 08017, Barcelona, Spain.; Medica Scientia Innovation Research, 08007, Barcelona, Spain.; Medica Scientia Innovation Research, Ridgewood, NJ, 07450, USA., Cortés J; 'Contigo Contra el Cáncer de la Mujer' Foundation, 28010, Madrid, Spain.; Centre for Biomedical Research in Cancer Networks (CIBERONC), Carlos III Health Institute, 28029, Madrid, Spain.; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron-salud Group, 08017, Barcelona, Spain.; Medica Scientia Innovation Research, 08007, Barcelona, Spain.; Medica Scientia Innovation Research, Ridgewood, NJ, 07450, USA.; Department of Medicine, Faculty of Biomedical and Health Sciences, European University of Madrid, 28670, Madrid, Spain.; IOB Institute of Oncology Madrid, Hospital Beata María Ana, Madrid, Spain., Smolkova B; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska Cesta 9, 84505, Bratislava, Slovakia. bozena.smolkova@savba.sk., Palacios J; Molecular Pathology of Cancer Group, Ramón y Cajal Health Research Institute (IRYCIS), 28034, Madrid, Spain. jose.palacios@salud.madrid.org.; Centre for Biomedical Research in Cancer Networks (CIBERONC), Carlos III Health Institute, 28029, Madrid, Spain. jose.palacios@salud.madrid.org.; Department of Pathology, Ramón y Cajal University Hospital, 28034, Madrid, Spain. jose.palacios@salud.madrid.org.; Faculty of Medicine, University of Alcalá, 28801, Madrid, Spain. jose.palacios@salud.madrid.org.
Publikováno v:
Virchows Archiv : an international journal of pathology [Virchows Arch] 2024 Aug; Vol. 485 (2), pp. 291-297. Date of Electronic Publication: 2024 May 07.
Autor:
Noguera-Castells A; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Vic, Barcelona, Catalonia, Spain; Department of Biosciences, Faculty of Science, Technology and Engineering, University of Vic-Central University of Catalonia (UVic-UCC), Vic, Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain., Parra J; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Vic, Barcelona, Catalonia, Spain., Davalos V; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Vic, Barcelona, Catalonia, Spain., García-Prieto CA; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Vic, Barcelona, Catalonia, Spain; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Catalonia, Spain., Veselinova Y; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Vic, Barcelona, Catalonia, Spain., Pérez-Miés B; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain; Department of Pathology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain; Department of Medicine and Medical Specialties, University of Alcalá, Alcalá de Henares (Madrid), Spain., Caniego-Casas T; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain; Department of Pathology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Palacios J; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain; Department of Pathology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain; Department of Medicine and Medical Specialties, University of Alcalá, Alcalá de Henares (Madrid), Spain., Saenz-Sardà X; Division of Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Englund E; Division of Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Musulen E; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Vic, Barcelona, Catalonia, Spain; Department of Pathology, Hospital Universitari General de Catalunya Grupo-QuirónSalud, Barcelona, Catalonia, Spain., Esteller M; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Vic, Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain. Electronic address: mesteller@carrerasresearch.org.
Publikováno v:
Chest [Chest] 2024 Apr; Vol. 165 (4), pp. 820-824. Date of Electronic Publication: 2023 Oct 31.
Autor:
Pozas Perez, J., Alonso Gordoa, T., Ruz-Caracuel, I., Caniego-Casas, T., Gonzalez Merino, C., San Roman Gil, M.V., Albarrán Fernández, V., Granados, A.R., Rodellar, J.M., Viana Aragonés, M., Palacios Calvo, J., Garrido Lopez, P., Molina Cerrillo, J.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S758-S758
Autor:
Pizarro D; Pathology Department, University Hospital Ramón y Cajal, IRYCIS, 28034 Madrid, Spain., Romero I; Instituto Valenciano de Oncología, 46009 Valencia, Spain.; Spanish Group for Investigation on Ovarian Cancer (GEICO), 28003 Madrid, Spain., Pérez-Mies B; Pathology Department, University Hospital Ramón y Cajal, IRYCIS, 28034 Madrid, Spain.; Biomedical Research Network in Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Faculty of Medicine, University of Alcalá, 28801 Alcalá de Henares, Spain., Redondo A; Spanish Group for Investigation on Ovarian Cancer (GEICO), 28003 Madrid, Spain.; Oncology Department, University Hospital La Paz, IdiPAZ, 28046 Madrid, Spain.; Instituto de Investigación Sanitaria del Hospital Universitario La Paz, 28029 Madrid, Spain.; Faculty of Medicine, Autonomous University of Madrid, 28029 Madrid, Spain., Caniego-Casas T; Pathology Department, University Hospital Ramón y Cajal, IRYCIS, 28034 Madrid, Spain.; Biomedical Research Network in Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain., Carretero-Barrio I; Pathology Department, University Hospital Ramón y Cajal, IRYCIS, 28034 Madrid, Spain.; Biomedical Research Network in Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Faculty of Medicine, University of Alcalá, 28801 Alcalá de Henares, Spain., Cristóbal E; Biomedical Research Network in Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain., Gutiérrez-Pecharromán A; Pathology Department, University Hospital Getafe, 28905 Getafe, Spain., Santaballa A; Spanish Group for Investigation on Ovarian Cancer (GEICO), 28003 Madrid, Spain.; Oncology Department, University Hospital La Fe, 46026 Valencia, Spain., D'Angelo E; Department of Medical, Oral, and Biotechnological Sciences, University 'G.D'Annunzio' of Chieti-Pescara, 66013 Chieti, Italy., Hardisson D; Biomedical Research Network in Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Instituto de Investigación Sanitaria del Hospital Universitario La Paz, 28029 Madrid, Spain.; Faculty of Medicine, Autonomous University of Madrid, 28029 Madrid, Spain.; Pathology Department, University Hospital La Paz, 28046 Madrid, Spain., Vieites B; Pathology Department, University Hospital Virgen del Rocío, 41013 Sevilla, Spain., Matías-Guiu X; Biomedical Research Network in Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Pathology and Medical Oncology Departments, Hospital Universitari Arnau de Vilanova, IRBLLEIDA, University of Lleida, 25003 Lleida, Spain.; Pathology Department, Hospital Universitari de Bellvitge, IDIBELL, University of Barcelona, 08007 Barcelona, Spain., Estévez P; Spanish Group for Investigation on Ovarian Cancer (GEICO), 28003 Madrid, Spain.; Oncology Department, University Hospital Virgen del Rocío, 41013 Sevilla, Spain.; Seville Biomedical Research Institute (IBIS), 41013 Sevilla, Spain., Guerra E; Spanish Group for Investigation on Ovarian Cancer (GEICO), 28003 Madrid, Spain.; Oncology Department, University Hospital Ramón y Cajal, IRYCIS, 28034 Madrid, Spain., Prat J; Pathology Department, Emeritus Faculty, Autonomous University of Barcelona, 08193 Barcelona, Spain., Poveda A; Spanish Group for Investigation on Ovarian Cancer (GEICO), 28003 Madrid, Spain.; Initia Oncología, Hospital Quironsalud Valencia, 46010 Valencia, Spain., López-Guerrero JA; Instituto Valenciano de Oncología, 46009 Valencia, Spain.; Spanish Group for Investigation on Ovarian Cancer (GEICO), 28003 Madrid, Spain., Palacios J; Pathology Department, University Hospital Ramón y Cajal, IRYCIS, 28034 Madrid, Spain.; Spanish Group for Investigation on Ovarian Cancer (GEICO), 28003 Madrid, Spain.; Biomedical Research Network in Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Faculty of Medicine, University of Alcalá, 28801 Alcalá de Henares, Spain.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2023 Jul 06; Vol. 24 (13). Date of Electronic Publication: 2023 Jul 06.
Autor:
Carretero-Barrio I; Servicio de Anatomía Patológica, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.; Faculty of Medicine, Universidad de Alcalá, 28801 Alcalá de Henares, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.; Unidad de Patología Mamaria, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain., Caniego-Casas T; Servicio de Anatomía Patológica, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain., Rosas M; Servicio de Anatomía Patológica, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain., Sánchez MC; Unidad de Patología Mamaria, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.; Servicio de Ginecología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain., Martínez-Jáñez N; Unidad de Patología Mamaria, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.; Servicio de Oncología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain., Chiva M; Unidad de Patología Mamaria, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.; Servicio de Radiología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain., Sarrió D; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.; Departamento de Bioquímica, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols', Conexión Cáncer (UAM-CSIC), 28029 Madrid, Spain., Moreno-Bueno G; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.; Departamento de Bioquímica, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols', Conexión Cáncer (UAM-CSIC), 28029 Madrid, Spain.; Fundación MD Anderson Internacional, 28033 Madrid, Spain., Palacios J; Servicio de Anatomía Patológica, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.; Faculty of Medicine, Universidad de Alcalá, 28801 Alcalá de Henares, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.; Unidad de Patología Mamaria, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain., Pérez-Mies B; Servicio de Anatomía Patológica, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.; Faculty of Medicine, Universidad de Alcalá, 28801 Alcalá de Henares, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.; Unidad de Patología Mamaria, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Mar 09; Vol. 15 (6). Date of Electronic Publication: 2023 Mar 09.
Autor:
Leskela S; Institute Ramón y Cajal for Health Research.; CIBER-ONC, Carlos III Health Institute., Romero I; Clinical Area of Gynecological Oncology., Cristobal E; Institute Ramón y Cajal for Health Research., Pérez-Mies B; CIBER-ONC, Carlos III Health Institute.; Department of Pathology, Hospital Ramón y Cajal., Rosa-Rosa JM; Institute Ramón y Cajal for Health Research.; CIBER-ONC, Carlos III Health Institute., Gutierrez-Pecharroman A; Department of Pathology, Hospital Ramón y Cajal., Caniego-Casas T; Institute Ramón y Cajal for Health Research., Santón A; CIBER-ONC, Carlos III Health Institute.; Department of Pathology, Hospital Ramón y Cajal., Ojeda B; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau., López-Reig R; Laboratory of Molecular Biology, Valencian Institute of Oncology., Palacios-Berraquero ML; Department of Hematology and Hemotherapy, Navarra University Clinic., García Á; Department of Pathology, Hospital Universitari Vall d'Hebron, Barcelona., Ibarra J; Department of Pathology, Hospital Son Llàtzer, Palma de Mallorca., Hakim S; Department of Pathology, Hospital Miguel Servet, Zaragoza, Spain., Guarch R; Department of Pathology, Hospital de Navarra, Pamplona., López-Guerrero JA; Laboratory of Molecular Biology, Valencian Institute of Oncology., Poveda A; Oncogynecologic Department, Initia Oncology, Hospital Quironsalud Valencia, Valencia., Palacios J; Institute Ramón y Cajal for Health Research.; CIBER-ONC, Carlos III Health Institute.; Department of Pathology, Hospital Ramón y Cajal.; Faculty of Medicine, University of Alcalá de Henares, Madrid.
Publikováno v:
The American journal of surgical pathology [Am J Surg Pathol] 2020 May; Vol. 44 (5), pp. 649-656.
Autor:
Pérez-Mies B; Pathology, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Instituto Ramon y Cajal de Investigación Sanitaria, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Faculty of Medicine, Alcalá University, Alcalá de Henares, Spain., Caniego-Casas T; Pathology, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Instituto Ramon y Cajal de Investigación Sanitaria, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Bardi T; Instituto Ramon y Cajal de Investigación Sanitaria, Madrid, Spain.; Department of Anesthesiology and Surgical Critical Care, Hospital Ramón y Cajal, Madrid, Spain., Carretero-Barrio I; Pathology, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Instituto Ramon y Cajal de Investigación Sanitaria, Madrid, Spain.; Faculty of Medicine, Alcalá University, Alcalá de Henares, Spain., Benito A; Pathology, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Instituto Ramon y Cajal de Investigación Sanitaria, Madrid, Spain.; Faculty of Medicine, Alcalá University, Alcalá de Henares, Spain., García-Cosío M; Pathology, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Instituto Ramon y Cajal de Investigación Sanitaria, Madrid, Spain.; Faculty of Medicine, Alcalá University, Alcalá de Henares, Spain., González-García I; Pathology, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Instituto Ramon y Cajal de Investigación Sanitaria, Madrid, Spain., Pizarro D; Pathology, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Instituto Ramon y Cajal de Investigación Sanitaria, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Rosas M; Pathology, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Instituto Ramon y Cajal de Investigación Sanitaria, Madrid, Spain., Cristóbal E; Pathology, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Instituto Ramon y Cajal de Investigación Sanitaria, Madrid, Spain., Ruano Y; Department of Pathology, Medical School, Universidad Complutense, Instituto i + 12, Hospital Universitario 12 de Octubre, Madrid, Spain., Garrido MC; Department of Pathology, Medical School, Universidad Complutense, Instituto i + 12, Hospital Universitario 12 de Octubre, Madrid, Spain., Rigual-Bobillo J; Instituto Ramon y Cajal de Investigación Sanitaria, Madrid, Spain.; Department of Respiratory, Hospital Universitario Ramón y Cajal, Madrid, Spain., de Pablo R; Instituto Ramon y Cajal de Investigación Sanitaria, Madrid, Spain.; Faculty of Medicine, Alcalá University, Alcalá de Henares, Spain.; Medical Intensive Care Unit, Hospital Ramón y Cajal, Madrid, Spain., Galán JC; Instituto Ramon y Cajal de Investigación Sanitaria, Madrid, Spain.; Clinical Microbiology Unit, Hospital Ramón y Cajal, Madrid, Spain.; Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain., Pestaña D; Instituto Ramon y Cajal de Investigación Sanitaria, Madrid, Spain.; Faculty of Medicine, Alcalá University, Alcalá de Henares, Spain.; Department of Anesthesiology and Surgical Critical Care, Hospital Ramón y Cajal, Madrid, Spain., Palacios J; Pathology, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Instituto Ramon y Cajal de Investigación Sanitaria, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Faculty of Medicine, Alcalá University, Alcalá de Henares, Spain.
Publikováno v:
Frontiers in medicine [Front Med (Lausanne)] 2022 Nov 03; Vol. 9, pp. 976759. Date of Electronic Publication: 2022 Nov 03 (Print Publication: 2022).
Autor:
Pérez-Mies B; Department of Pathology, Hospital Ramón y Cajal.; Instituto Ramon y Cajal de Investigación Sanitaria (IRyCIS).; CIBERONC.; Faculty of Medicine, Universidad de Alcalá., Caniego-Casas T; Department of Pathology, Hospital Ramón y Cajal.; Instituto Ramon y Cajal de Investigación Sanitaria (IRyCIS).; CIBERONC., Carretero-Barrio I; Department of Pathology, Hospital Ramón y Cajal.; Instituto Ramon y Cajal de Investigación Sanitaria (IRyCIS).; Faculty of Medicine, Universidad de Alcalá., Biscuola M; CIBERONC.; Department of Pathology, Hospital Universitario Virgen del Rocío, Sevilla, Spain., López-García MA; CIBERONC.; Department of Pathology, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Hardisson D; CIBERONC.; Department of Pathology, Hospital Universitario La Paz.; Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdidPAZ).; Faculty of Medicine, Universidad Autónoma de Madrid., Rosas M; Department of Pathology, Hospital Ramón y Cajal.; Instituto Ramon y Cajal de Investigación Sanitaria (IRyCIS)., López Rodríguez MJ; Instituto Ramon y Cajal de Investigación Sanitaria (IRyCIS).; Department of Gynecology, Hospital Universitario Ramón y Cajal, Madrid., Cristóbal E; Department of Pathology, Hospital Ramón y Cajal.; Instituto Ramon y Cajal de Investigación Sanitaria (IRyCIS)., Pizarro D; Department of Pathology, Hospital Ramón y Cajal.; Instituto Ramon y Cajal de Investigación Sanitaria (IRyCIS)., Rosa-Rosa JM; Department of Pathology, Hospital Ramón y Cajal.; Instituto Ramon y Cajal de Investigación Sanitaria (IRyCIS)., Palacios J; Department of Pathology, Hospital Ramón y Cajal.; Instituto Ramon y Cajal de Investigación Sanitaria (IRyCIS).; CIBERONC.; Faculty of Medicine, Universidad de Alcalá.
Publikováno v:
The American journal of surgical pathology [Am J Surg Pathol] 2022 Nov 01; Vol. 46 (11), pp. 1545-1553. Date of Electronic Publication: 2022 Jul 25.